Morepen Laboratories Limited
Live Market Data
About Company
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Industry Segment
Price Chart
Technical Analysis
Technical Outlook
Valuation Check
Research Reports
Peer Comparison
Related Sector| Company | Price | P/E | M.Cap (Cr) | ROE % |
|---|---|---|---|---|
MARKSANS PHARMA LIMITED MARKSANS | ₹168.15 | 21.15 | 7,620 | - |
HFCL LIMITED HFCL | ₹71.72 | 199.22 | 10,975 | - |
TRIDENT LIMITED TRIDENT | ₹24.12 | 30.15 | 12,304 | - |
MANALI PETROCHEMICALS LT MANALIPETC | ₹42.86 | 6.60 | 740 | - |
LAURUS LABS LIMITED LAURUSLABS | ₹1,042.9 | 66.68 | 56,315 | - |
Quarterly Results
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Revenue (Cr) | 484.16 | 411.58 | 425.24 | 458.01 | 452.78 |
| Net Income (Cr) | 27.51 | 40.87 | 10.75 | 20.32 | 26.69 |
| EPS (₹) | 0.5 | 0.75 | 0.2 | 0 | 0.49 |
Annual Profit & Loss
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue (Cr) | 1,803.73 | 1,682.13 | 1,413.95 | 1,541.57 |
| Operating Exp (Cr) | 472.97 | 473.46 | 391.98 | 371.6 |
| Net Income (Cr) | 118.02 | 96.16 | 38.68 | 101.68 |
| EPS (₹) | 2.2 | 1.88 | 0.77 | 2.26 |
Balance Sheet
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Assets (Cr) | - | 1,736.14 | - | 1,778.1 | - |
| Total Liabilities (Cr) | - | 539.19 | - | 591.14 | - |
| Total Equity (Cr) | - | 1,196.23 | - | 1,156.23 | - |
Key Ratios Fundamentals
Valuation
Profitability
Liquidity & Debt
Price Statistics
Pattern Unavailable
Detailed shareholding breakdown is not currently provided by the exchange.